<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00614198</url>
  </required_header>
  <id_info>
    <org_study_id>KA 0503g</org_study_id>
    <nct_id>NCT00614198</nct_id>
  </id_info>
  <brief_title>ScanBrit Dietary Intervention in Autism</brief_title>
  <acronym>ScanBrit</acronym>
  <official_title>The ScanBrit Randomised Controlled Study of Gluten- and Casein-free Dietary Intervention for Children With Autism Spectrum Disorders</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Center for Autisme, Denmark</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Norway: Bo Nils og Seim Family Settlement</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>The Robert Luff Foundation, United Kingdom</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Eric Birger Christensen Fond, Denmark</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Norsk Proteinintolerance, Norway</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Center for Autisme, Denmark</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      A growing body of research indicates that dietary intervention excluding foods containing the
      proteins, gluten and casein, from the diet of children diagnosed with an autism spectrum
      disorder (ASD) may have a positive effect on behaviour and developmental outcome.

      In this single-blind, randomised-controlled, matched-pair adaptive trial, we introduced a
      gluten- and casein-free (GFCF) diet to a group of pre-pubescent children diagnosed with ASD
      concurrently with an abnormal urinary profile. Following random allocation to a diet or non-
      diet group, stage 1 of the study saw an intervention group follow the GFCF diet for eight
      months initially - progressing to 12 months if required. A non-diet control group continued
      with a normal diet.

      Assuming significant changes for the dietary group on the various outcome measures of
      behaviour and development, stage 2 of the study saw both groups assigned to GFCF dietary
      intervention for a further 12 months when outcome measures were again assessed at study end.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Eligibility criteria: diagnosis of autism, no co-morbid diagnosis of Fragile X syndrome,
      epilepsy or tuberous sclerosis, aged between 4-10y11m.

      Experimental hypothesis: children with an autism spectrum disorder (ASD) on a GFCF diet would
      show a significantly improved group developmental outcome in the medium- and long-term with
      regards to core autism and/or secondary symptoms.

      Main outcome measures: change in scores of dietary participants on one or more measures
      against predefined statistical thresholds as evidence of improvement, alongside changes to
      intra- and inter-group scores at study endpoint.

      Main outcome measures ascertained by: Autism Diagnostic Observation Schedule (ADOS), Gillam
      Autism Rating Scale (GARS), Vineland Adaptive Behaviour Scales (VABS), Attention Deficit
      Hyperactivity Disorder - IV (ADHD-IV) scales.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>April 2006</start_date>
  <completion_date type="Actual">October 2008</completion_date>
  <primary_completion_date type="Actual">October 2008</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in Diet Groups Scores on One of Several Measures Used Against Pre-defined Statistical Thresholds as Evidence of Improvement.</measure>
    <time_frame>Baseline - 8 months - 12 months - 24 months</time_frame>
    <description>ADOS (Autism Diagnostic Observation Schedule): module 1 cutoff scores (communication+social): autism=12, autism spectrum (AS)=7; module 2 cutoffs: autism=12, AS=8; module 3 cutoffs: autism=10; AS=7. GARS (Gilliam Autism Rating Scale): &lt;80 low probability of autism, 81-90 below average, 91-110 average, &gt;110 above average probability of autism. VABS (Vineland Adaptive Behaviour Scale): &lt;69 (low ability), 70-84 (moderate/low), 85-115 (adequate), 116-130 (moderate/high), &gt;130 (high). ADHD-IV: 0=no problems indicated. &gt;11 attention &amp; &gt;11 hyperactivity = ADHD diagnosis.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Changes to Appearance of Multiple Compounds in Urine Samples</measure>
    <time_frame>Baseline - 8 months -12 months - 24 months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">72</enrollment>
  <condition>Autism</condition>
  <condition>Autism Spectrum Disorder (ASD)</condition>
  <arm_group>
    <arm_group_label>Gluten- and casein-free diet</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Stage 1: Gluten- and casein-free dietary intervention for first 8 or 12 months. 8 or 12 months: Interim analysis based on surpassing statistical thresholds. If showed group significant improvements then progressed to stage 2 (continued on a gluten- and casein-free diet for a further 12 months).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>No dietary intervention</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Stage 1: No special dietary intervention for first 8 or 12 months. 8 or 12 months: Interim analysis based on surpassing statistical thresholds. If gluten- and casein-free dietary group showed group significant improvements then progressed to stage 2 (introduction of a gluten- and casein-free diet for 12 months).</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Gluten- and casein-free diet</intervention_name>
    <description>Removal of foods containing gluten (cereal produce) and casein (dairy produce)</description>
    <arm_group_label>Gluten- and casein-free diet</arm_group_label>
    <other_name>Gluten-free (wheat-free), casein- free (milk-free) diets</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Autism Spectrum Disorder (ASD)

          -  Diagnosis received at Centre for Autism or a psychiatric clinic

          -  Abnormal urinary peptide profile

        Exclusion Criteria:

          -  Medical treatment

          -  Epilepsy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>4 Years</minimum_age>
    <maximum_age>11 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <link>
    <url>http://www.centerforautisme.dk</url>
    <description>Center for Autisme, Denmark</description>
  </link>
  <link>
    <url>http://www.espa-research.org.uk</url>
    <description>ESPA Research, UK</description>
  </link>
  <results_reference>
    <citation>Whiteley P, Haracopos D, Knivsberg AM, Reichelt KL, Parlar S, Jacobsen J, Seim A, Pedersen L, Schondel M, Shattock P. The ScanBrit randomised, controlled, single-blind study of a gluten- and casein-free dietary intervention for children with autism spectrum disorders. Nutr Neurosci. 2010 Apr;13(2):87-100. doi: 10.1179/147683010X12611460763922.</citation>
    <PMID>20406576</PMID>
  </results_reference>
  <verification_date>May 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 31, 2008</study_first_submitted>
  <study_first_submitted_qc>January 31, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 13, 2008</study_first_posted>
  <results_first_submitted>May 17, 2010</results_first_submitted>
  <results_first_submitted_qc>August 31, 2010</results_first_submitted_qc>
  <results_first_posted type="Estimate">October 1, 2010</results_first_posted>
  <last_update_submitted>August 31, 2010</last_update_submitted>
  <last_update_submitted_qc>August 31, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 1, 2010</last_update_posted>
  <responsible_party>
    <name_title>Director Demetrious Haracopos</name_title>
    <organization>Center for Autisme</organization>
  </responsible_party>
  <keyword>autism</keyword>
  <keyword>autism spectrum disorder</keyword>
  <keyword>diet</keyword>
  <keyword>gluten</keyword>
  <keyword>casein</keyword>
  <keyword>intervention</keyword>
  <keyword>peptide</keyword>
  <keyword>randomised</keyword>
  <keyword>controlled</keyword>
  <keyword>adaptive design</keyword>
  <keyword>Autism Diagnostic Observation Schedule (ADOS)</keyword>
  <keyword>Gilliam Autism Rating Scale (GARS)</keyword>
  <keyword>Vineland Adaptive Behaviour Scale (VABS)</keyword>
  <keyword>Attention-Deficit Hyperactivity Disorder (ADHD)-IV Scale</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Autistic Disorder</mesh_term>
    <mesh_term>Autism Spectrum Disorder</mesh_term>
    <mesh_term>Child Development Disorders, Pervasive</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Caseins</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Recruitment via multiple associations</recruitment_details>
      <pre_assignment_details>92 participants were initially identified for possible study recruitment. 82 participants were available for possible study allocation; 10 participants dropped out prior to randomisation for various reasons, leaving 72 participants.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Gluten- and Casein-free Dietary Intervention</title>
          <description>Stage 1: Gluten- and casein-free dietary intervention for first 8 or 12 months. 8 or 12 months: Interim analysis based on surpassing statistical thresholds. If showed group significant improvement progressed to stage 2 (continued on a gluten- and casein-free diet for a further 12 months).</description>
        </group>
        <group group_id="P2">
          <title>No Gluten- and Casein-free Dietary Intervention</title>
          <description>Stage 1: No special dietary intervention for first 8 or 12 months. 8 or 12 months: Interim analysis based on surpassing statistical thresholds. If dietary intervention group showed group significant improvement progressed to stage 2 (introduction of a gluten- and casein-free diet for 12 months).</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Stage 1</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="38"/>
                <participants group_id="P2" count="34"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="26"/>
                <participants group_id="P2" count="29"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="12"/>
                <participants group_id="P2" count="5"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
        <period>
          <title>Stage 2</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="26"/>
                <participants group_id="P2" count="29">Reallocated to gluten- and casein-free dietary intervention</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="18"/>
                <participants group_id="P2" count="17"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="8"/>
                <participants group_id="P2" count="12"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Gluten- and Casein-free Dietary Intervention</title>
          <description>Stage 1: Gluten- and casein-free dietary intervention for first 8 or 12 months. 8 or 12 months: Interim analysis based on surpassing statistical thresholds. If showed group significant improvement progressed to stage 2 (continued on a gluten- and casein-free diet for a further 12 months).</description>
        </group>
        <group group_id="B2">
          <title>No Gluten- and Casein-free Dietary Intervention</title>
          <description>Stage 1: No special dietary intervention for first 8 or 12 months. 8 or 12 months: Interim analysis based on surpassing statistical thresholds. If dietary intervention group showed group significant improvement progressed to stage 2 (introduction of a gluten- and casein-free diet for 12 months).</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="38"/>
            <count group_id="B2" value="34"/>
            <count group_id="B3" value="72"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>&lt;=18 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="38"/>
                    <measurement group_id="B2" value="34"/>
                    <measurement group_id="B3" value="72"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Between 18 and 65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;=65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="8.22" spread="1.99"/>
                    <measurement group_id="B2" value="8.13" spread="2.03"/>
                    <measurement group_id="B3" value="8.15" spread="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="33"/>
                    <measurement group_id="B2" value="31"/>
                    <measurement group_id="B3" value="64"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Denmark</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="38"/>
                    <measurement group_id="B2" value="34"/>
                    <measurement group_id="B3" value="72"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Change in Diet Groups Scores on One of Several Measures Used Against Pre-defined Statistical Thresholds as Evidence of Improvement.</title>
        <description>ADOS (Autism Diagnostic Observation Schedule): module 1 cutoff scores (communication+social): autism=12, autism spectrum (AS)=7; module 2 cutoffs: autism=12, AS=8; module 3 cutoffs: autism=10; AS=7. GARS (Gilliam Autism Rating Scale): &lt;80 low probability of autism, 81-90 below average, 91-110 average, &gt;110 above average probability of autism. VABS (Vineland Adaptive Behaviour Scale): &lt;69 (low ability), 70-84 (moderate/low), 85-115 (adequate), 116-130 (moderate/high), &gt;130 (high). ADHD-IV: 0=no problems indicated. &gt;11 attention &amp; &gt;11 hyperactivity = ADHD diagnosis.</description>
        <time_frame>Baseline - 8 months - 12 months - 24 months</time_frame>
        <population>Per protocol analysis. Analysis was conducted on n=26 (Gluten- and casein-free dietary intervention) and n=29 (No gluten- and casein-free dietary intervention) at 12 months. Analysis was conducted on n=18 and n=17 at 24 months (both on gluten- and casein-free dietary intervention).</population>
        <group_list>
          <group group_id="O1">
            <title>Gluten- and Casein-free Dietary Intervention</title>
            <description>Stage 1: Gluten- and casein-free dietary intervention for first 8 or 12 months. 8 or 12 months: Interim analysis based on surpassing statistical thresholds. If showed group significant improvement progressed to stage 2 (continued on a gluten- and casein-free diet for a further 12 months).</description>
          </group>
          <group group_id="O2">
            <title>No Gluten- and Casein-free Dietary Intervention</title>
            <description>Stage 1: No special dietary intervention for first 8 or 12 months. 8 or 12 months: Interim analysis based on surpassing statistical thresholds. If dietary intervention group showed group significant improvement progressed to stage 2 (introduction of a gluten- and casein-free diet for 12 months).</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Diet Groups Scores on One of Several Measures Used Against Pre-defined Statistical Thresholds as Evidence of Improvement.</title>
          <description>ADOS (Autism Diagnostic Observation Schedule): module 1 cutoff scores (communication+social): autism=12, autism spectrum (AS)=7; module 2 cutoffs: autism=12, AS=8; module 3 cutoffs: autism=10; AS=7. GARS (Gilliam Autism Rating Scale): &lt;80 low probability of autism, 81-90 below average, 91-110 average, &gt;110 above average probability of autism. VABS (Vineland Adaptive Behaviour Scale): &lt;69 (low ability), 70-84 (moderate/low), 85-115 (adequate), 116-130 (moderate/high), &gt;130 (high). ADHD-IV: 0=no problems indicated. &gt;11 attention &amp; &gt;11 hyperactivity = ADHD diagnosis.</description>
          <population>Per protocol analysis. Analysis was conducted on n=26 (Gluten- and casein-free dietary intervention) and n=29 (No gluten- and casein-free dietary intervention) at 12 months. Analysis was conducted on n=18 and n=17 at 24 months (both on gluten- and casein-free dietary intervention).</population>
          <units>Units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="26"/>
                <count group_id="O2" value="29"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>ADOS - Communication (8 months)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.16715" spread="0.10127"/>
                    <measurement group_id="O2" value="0.08235" spread="0.12096"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>ADOS - Communication (24 months)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.16176" spread="0.1204"/>
                    <measurement group_id="O2" value="0.18529" spread="0.11926"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>ADOS - Social (8 months)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.016807" spread="0.1024"/>
                    <measurement group_id="O2" value="0.02521" spread="0.12203"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>ADOS - Social (24 months)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.5042" spread="0.09795"/>
                    <measurement group_id="O2" value="0.02521" spread="0.13709"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>ADOS - Repetitive behaviours (8 months)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.14706" spread="0.0894"/>
                    <measurement group_id="O2" value="0.03431" spread="0.1139"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>ADOS - Reptitive behaviours (24 months)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.14216" spread="0.0782"/>
                    <measurement group_id="O2" value="-0.0049" spread="0.10042"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>GARS - Social (8 months)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.07692" spread="0.29382"/>
                    <measurement group_id="O2" value="-0.06897" spread="0.27152"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>GARS - Social (12 months)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.57692" spread="0.3097"/>
                    <measurement group_id="O2" value="-0.42308" spread="0.36867"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>GARS - Social (24 months)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.88235" spread="0.57447"/>
                    <measurement group_id="O2" value="-1.11765" spread="0.50645"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>GARS - Communication (8 months)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.23077" spread="0.38554"/>
                    <measurement group_id="O2" value="-0.51724" spread="0.40203"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>GARS - Communication (12 months)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.47826" spread="0.37125"/>
                    <measurement group_id="O2" value="-1.46154" spread="0.40089"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>GARS - Communication (24 months)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-2" spread="0.42875"/>
                    <measurement group_id="O2" value="-1.29412" spread="0.60491"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>GARS - Stereotyped behaviours (8 months)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.96154" spread="0.32572"/>
                    <measurement group_id="O2" value="-0.7931" spread="0.41338"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>GARS - Stereotyped behaviours (12 months)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.46154" spread="0.33389"/>
                    <measurement group_id="O2" value="-1.3333" spread="0.39943"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>GARS - Stereotyped behaviours (24 months)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.88235" spread="0.44459"/>
                    <measurement group_id="O2" value="-1.70588" spread="0.52696"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>VABS - Communication (8 months)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.23077" spread="1.35227"/>
                    <measurement group_id="O2" value="1.25" spread="1.73176"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>VABS - Communication (12 months)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.92308" spread="2.71629"/>
                    <measurement group_id="O2" value="1.85714" spread="2.05204"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>VABS - Communication (24 months)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.27778" spread="3.61895"/>
                    <measurement group_id="O2" value="-2.05882" spread="3.19175"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>VABS - Social (8 months)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.53846" spread="2.03676"/>
                    <measurement group_id="O2" value="0.92857" spread="2.63369"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>VABS - Social (12 months)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-4.15385" spread="2.39467"/>
                    <measurement group_id="O2" value="-3.25" spread="2.59406"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>VABS - Social (24 months)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.72222" spread="3.17033"/>
                    <measurement group_id="O2" value="-3.29412" spread="4.29412"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>VABS - Daily Living (8 months)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.03846" spread="2.54043"/>
                    <measurement group_id="O2" value="-1.64286" spread="2.90785"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>VABS - Daily Living (12 months)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.46154" spread="2.79903"/>
                    <measurement group_id="O2" value="-2.85714" spread="2.8857"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>VABS - Daily Living (24 months)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.16667" spread="2.94974"/>
                    <measurement group_id="O2" value="-4.64706" spread="4.46715"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>ADHD-IV - Inattention (8 months)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-2.15385" spread="0.916"/>
                    <measurement group_id="O2" value="0.31034" spread="0.65296"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>ADHD-IV - Inattention (12 months)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-2.19231" spread="0.88582"/>
                    <measurement group_id="O2" value="-0.03704" spread="0.69488"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>ADHD-IV - Inattention (24 months)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-2.29412" spread="0.89016"/>
                    <measurement group_id="O2" value="-3.35294" spread="1.14706"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>ADHD-IV - Hyperactivity (8 months)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-2.03846" spread="0.80667"/>
                    <measurement group_id="O2" value="-0.17241" spread="0.60186"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>ADHD-IV - Hyperactivity (12 months)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.69231" spread="0.86606"/>
                    <measurement group_id="O2" value="-0.92593" spread="0.55451"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>ADHD-IV Hyperactivity (24 months)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-2.58824" spread="1.12805"/>
                    <measurement group_id="O2" value="-4.17647" spread="1.22845"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>1st stage analysis (baseline-8m or 12m) used a repeated measures model for all assessment measures. Model included baseline, age, time and time*treatment interaction. Results informed 2nd stage (8 or 12 months - 20 or 24 months). 2nd stage analysis based on various statistical scenarios (baseline vs 12 months on intervention, 12 months of no intervention vs 12 on intervention, baseline vs 24 months on intervention). No ADOS assessments were used at 12 months because of risk of practice effects.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.01</p_value>
            <p_value_desc>A priori p threshold set for stage 1 (baseline - 8m; p&lt;0.01) or (baseline - 12 months, p&lt;0.05) in order to progress to stage 2 (8 or 12 months - 20 or 24 months).</p_value_desc>
            <method>Mixed Models Analysis</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Changes to Appearance of Multiple Compounds in Urine Samples</title>
        <time_frame>Baseline - 8 months -12 months - 24 months</time_frame>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Any indications of adverse events were continually monitored throughout the study period by study nutritionist. Assessments carried out at 8, 12 and 24 months represent periods where any adverse events could be reported.</time_frame>
      <desc>All participants on dietary intervention were potentially at mild risk from the introduction of a new dietary regime (gluten- and casein-free diet). Risk would include: disruption to eating habits &amp; behavioural problems (associated with change to routine). Data was not collected on such mild risks.</desc>
      <group_list>
        <group group_id="E1">
          <title>Gluten- and Casein-free Dietary Intervention</title>
          <description>Stage 1: Gluten- and casein-free dietary intervention for first 8 or 12 months. 8 or 12 months: Interim analysis based on surpassing statistical thresholds. If showed group significant improvement progressed to stage 2 (continued on a gluten- and casein-free diet for a further 12 months).</description>
        </group>
        <group group_id="E2">
          <title>No Gluten- and Casein-free Dietary Intervention</title>
          <description>Stage 1: No special dietary intervention for first 8 or 12 months. 8 or 12 months: Interim analysis based on surpassing statistical thresholds. If dietary intervention group showed group significant improvement progressed to stage 2 (introduction of a gluten- and casein-free diet for 12 months).</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="34"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="38"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="34"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>Single-blind trial, no placebo condition, analysis based on per protocol (not intention to treat), socio-economic status not recorded, independent screening for underlying somatic conditions potentially associated with results not undertaken</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Lennart Pedersen</name_or_title>
      <organization>Center for Autisme</organization>
      <phone>44982355</phone>
      <email>lpe@centerforautisme.dk</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

